Triple AntibioticMaximum Strength (Budpak Inc.)


Welcome to the PulseAid listing for the Triple Antibiotic drug offered from Budpak Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Budpak Inc.
NON-PROPRIETARY NAME: Bacitracin Zinc Neomycin Polymyxin B Sulfate
SUBSTANCE NAME: BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2011-08-19
END MARKETING DATE: 0000-00-00


Triple Antibiotic Maximum Strength HUMAN OTC DRUG Details:

Item DescriptionTriple Antibiotic Maximum Strength from Budpak Inc.
LABELER NAME: Budpak Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 400; 3.5; 5000([USP’U]/g; mg/g; [USP’U]/g)
START MARKETING DATE: 2011-08-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 27293-014_1feefbdd-7a58-4862-a59b-a3263051e67d
PRODUCT NDC: 27293-014
APPLICATION NUMBER: part333B

Other BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Budpak Inc.Triple Antibiotic
Melaleuca, Inc.Triple Antibiotic